FDA — authorised 23 December 2005
- Application: BLA125118
- Marketing authorisation holder: BRISTOL MYERS SQUIBB
- Local brand name: ORENCIA
- Indication: INJECTABLE — IV (INFUSION)
- Status: approved
🇺🇸 Subcutaneous (SC) abatacept in United States
FDA authorised Subcutaneous (SC) abatacept on 23 December 2005
Marketing authorisation
Other Immunology approved in United States
Frequently asked questions
Is Subcutaneous (SC) abatacept approved in United States?
Yes. FDA authorised it on 23 December 2005.
Who is the marketing authorisation holder for Subcutaneous (SC) abatacept in United States?
BRISTOL MYERS SQUIBB holds the US marketing authorisation.